113 results
Page 2 of 6
8-K
EX-99.1
4lz6gr0bn
10 Jul 23
Regulation FD Disclosure
4:06pm
8-K
EX-99.1
s7es 1imdqx0
9 May 23
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
p9rmqg1ewieyi9giod
3 May 23
Soleno Therapeutics Completes Enrollment in Randomized Withdrawal Period of Study C602 of DCCR for Prader-Willi Syndrome
5:26pm
8-K
ne0z9gdw
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-99.1
05sr j5e3i
9 Nov 22
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:11pm
8-K
EX-99.1
52ps ob4zy
10 Aug 22
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results
4:06pm
8-K/A
r7njw ttk5vlvh
25 Jul 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
EX-99.1
777c6o7 xtim
10 May 22
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
4:01pm
424B5
5tqac9wi
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
yjjzi
28 Mar 22
Prospectus supplement for primary offering
4:53pm